Delivery Order SPE2DB22D3016-SPE2DB25FBES9
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $1,691.15 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,603.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $3,892.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $16,036.57. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 19, 2025. The award represents pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a $1,767.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. The contract, which represents a non-set-aside competitive award, is scheduled for ultimate completion by August 18, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,118.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $3,314.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a purchase of pharmaceutical products to support federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 3 mg/0.5 mL pen auto-injectors valued at $3,241.02 with a firm fixed price structure. This order is part of a competitively awarded, non-set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that serves as a...
- The Defense Logistics Agency awarded a $3,003.00 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBES9Delivery Order
The Defense Logistics Agency awarded a $21,491.13 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This specific delivery order for Trulicity, a diabetes treatment medication, reflects the company's ongoing role as a primary supplier of brand-name and generic medications to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.5k | 8/12/25 |